Sage Journals: Discover world-class research

Retricted access

Research article

First published 2023-04-03

Prediction of ITK inhibitor kinases activity based on posterior probabilistic weighted average based ensemble voting classification

Rama Devi Chalasani, Y. Radhika

Journal of Intelligent & Fuzzy Systems: Applications in Engineering and Technology

Retricted access

Research article

First published 2025-03

Therapeutic Targeting of Interleukin-2-Inducible T-Cell Kinase (ITK) for Cancer and Immunological Disorders: Potential Next-Generation ITK Inhibitors

Shazia Ahmed, Mohammad Umar Saeed, Arunabh Choudhury [...]

OMICS: A Journal of Integrative Biology

Retricted access

Research article

First published 2007-12

A FLIPR-Based Assay to Assess Potency and Selectivity of Inhibitors of the TEC Family Kinases Btk and Itk

John Douhan, Joy S. Miyashiro, Xiaochuan Zhou [...]

ASSAY and Drug Development Technologies

Free access

Research article

First published 2007-02

Three Mechanistically Distinct Kinase Assays Compared: Measurement of Intrinsic ATPase Activity Identified the Most Comprehensive Set of ITK Inhibitors

Mohammed A. Kashem, Richard M. Nelson, Jeffrey D. Yingling [...]

Journal of Biomolecular Screening

Free access

Research article

First published 2019-9

Identification of a New Inhibitor That Stabilizes Interleukin-2-Inducible T-Cell Kinase in Its Inactive Conformation

Rie Hantani, Saya Hanawa, Shohei Oie [...]

Journal of Biomolecular Screening

Open access

Review article

First published 2021

The role of acalabrutinib in adults with chronic lymphocytic leukemia

Bita Fakhri, Charalambos Andreadis

Therapeutic Advances in Hematology

Open access

Research article

First published 2021-12-03

Phase Ib/II trial of Ibrutinib and Nivolumab in Patients with Advanced Refractory Renal Cell Carcinoma 1

Mamta Parikh, Matthew E. Tenold, Lihong Qi [...]

Kidney Cancer

Open access

Research article

First published 2025

Pretreatment CT-Based Machine Learning Radiomics Model Predicts Response in Inoperable Stage III NSCLC Treated with Concurrent Radiochemotherapy Plus PD-1 Inhibitors

Ya Li, Min Zhang, Yong Hu [...]

Technology in Cancer Research & Treatment

Search results